Protecting Kids from Pneumonia Waldorf MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Waldorf.

Cambridge Pediatrics Center
(301) 645-6670
3460 Old Washington Road
Waldorf, MD
 
Chon S C MD
(301) 645-8322
7 Post Office Road Suite C
Waldorf, MD
 
Aziza C Alam
(301) 843-7222
6 Post Office Rd
Waldorf, MD
Specialty
Pediatrics

Data Provided by:
Dianna E Abney
(301) 645-1133
3500 Old Washington Rd
Waldorf, MD
Specialty
Pediatrics

Data Provided by:
Poisson Sujata MD
(301) 843-0803
Pembrooke Square Med
Waldorf, MD
 
Diptee Drakash MD
(301) 645-4220
Pembrooke Square
Waldorf, MD
 
Kriger Frank L MD
(301) 843-9122
7 Post Office Road Suite C
Waldorf, MD
 
Soma Narasimha Reddy
(301) 645-6670
3460 Old Washington Rd
Waldorf, MD
Specialty
Pediatrics

Data Provided by:
Michael Eliot Greenberg, MD
(650) 364-6010
11637 Terrace Dr
Waldorf, MD
Specialties
Pediatrics
Gender
Male
Languages
French, Spanish, Hebrew
Education
Medical School: Med Coll Of Ga Sch Of Med, Augusta Ga 30912
Graduation Year: 1992
Hospital
Hospital: St Lukes Hosp, San Francisco, Ca; San Mateo County General Hosp, San Mateo, Ca
Group Practice: Fairoaks Family Health Ctr

Data Provided by:
Dr. Haith
(301) 645-1133
3500 Old Washington Rd # 301
Waldorf, MD
Gender
F
Speciality
Pediatrician
General Information
Hospital: Cambridge Pediatrics
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 1, reviews.

Data Provided by:
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com